After close contact with someone with COVID-19, the next step depends on timing, symptoms and personal risk. Prevention after exposure and treatment of an active infection are different services.
Use the selected clinic’s confirmed address and contact details. Before travel, name the specific service and ask about age eligibility, visit type and any required test or procedure. The general clinic hours do not establish every service’s schedule. Bring relevant records and confirm the result or follow-up route. Record when the contact occurred and whether you have symptoms or a positive test. Pregnancy and medicine interactions can rule out use. An active infection needs a separate treatment evaluation, particularly for people at higher risk. A prevention request must not delay assessment of symptoms.
After close contact with someone with COVID-19, the next step depends on timing, symptoms and personal risk. Prevention after exposure and treatment of an active infection are different services. A consultation reviews the exposure, tests when appropriate and considers whether a preventive prescription fits the current US indication.
XOCOVA (ensitrelvir) inhibits a SARS-CoV-2 protease. Its FDA-approved US indication is post-exposure prevention of COVID-19 in adults and adolescents age 12 or older following contact with an infected person. It should be started as soon as possible and within 72 hours of contact. This is a medication pathway, not a PCR test or a guarantee that infection will be prevented.
Record when the contact occurred and whether you have symptoms or a positive test. Pregnancy and medicine interactions can rule out use. An active infection needs a separate treatment evaluation, particularly for people at higher risk. A prevention request must not delay assessment of symptoms.
The clinician reviews the exposure, your health history, pregnancy potential and all medicines. Ask whether the proposed use matches the US label and what to do if symptoms develop. If appropriate, confirm the pharmacy can supply the medicine within the time window. A prescription that arrives after the window is not equivalent to timely prevention.
Prepare an exact exposure timeline, current test results and a complete medicine and supplement list. Tell the clinician about pregnancy, contraception and breastfeeding. The label requires pregnancy verification before use in people who can become pregnant. Do not withhold relevant medicines or change exposure details to obtain a prescription.
XOCOVA can cause fetal harm and has major drug interactions involving CYP3A and other pathways. Follow clinician and pharmacist advice about contraception and breastfeeding precautions; the label specifies precautions through 2 weeks after treatment. Call 911 for severe breathing difficulty, chest pressure, confusion or inability to stay awake.
Monitor symptoms and follow the clinician's testing and infection-prevention plan. A negative early test does not rule out infection after an exposure. If symptoms or a positive test develop, arrange reassessment for active COVID-19 care. Do not assume the preventive medicine makes you noninfectious.
Confirm appointment capacity, clinician familiarity, exact plan coverage and pharmacy stock immediately because the window is short. A virtual discussion may be feasible, but eligibility and prescribing depend on the actual service and patient location.
Nao Medical Astoria: 37-15 23rd Ave, Astoria, NY 11105. Call +1-917-310-3371 to confirm the specific service, clinician and appointment before travelling.
Contact the clinic to confirm this service, the clinician and appointment preparation. General clinic hours may differ from service appointment times.
Nao Medical Astoria is listed at 37-15 23rd Ave, Astoria, NY 11105. Confirm current hours, the specific service and age eligibility before travel. Call +1-917-310-3371 or use the clinic's established booking route.
Confirm the selected clinic can assess the exact concern today and whether to book or walk in. A visit does not guarantee the named drug or pharmacy supply. Xocova post-exposure prevention must start within 72 hours under its label; do not wait for routine booking if that window may close.
Bring a symptom timeline, medicine and allergy list, prior relevant reports, any written test order or required form, and plan details if using insurance. State the deadline for any document. Ask about preparation for the actual ordered test; do not fast or stop medicines without specific instructions.
Seek evaluation promptly after the exposure: Xocova must be started within 72 hours of contact with a person who has COVID-19 under its U.S. label. Insurance authorization, an appointment delay or pharmacy supply does not extend that window. Contact the prescriber immediately if supply or approval may be late so the clinician can reassess the plan. Do not start it outside the prescribed pathway or assume it treats an existing infection.
Xocova is post-exposure prevention, not immediate protection against every infection. Eligible patients must start within 72 hours of contact with a person who has COVID-19, according to the label. Infection can still occur. New symptoms or a positive test need clinical assessment rather than an assumption that preventive treatment has worked.
Xocova's U.S. indication is post-exposure prevention of COVID-19 in eligible adults and adolescents age 12 or older; it is not labeled to treat an existing positive COVID test or long COVID. If you test positive or develop symptoms, promptly ask a clinician about the appropriate assessment and treatment pathway, especially if you are at higher risk.
An immediate negative test cannot show that an exposure caused no infection. If symptoms develop, test promptly and seek clinical advice early if you are at higher risk of severe illness. For someone without symptoms after an exposure, FDA advises waiting at least 5 full days before testing with an at-home antigen test. Follow the exact kit instructions. After a negative antigen result, FDA recommends a second test 48 hours later when symptomatic, or three tests in total 48 hours apart when asymptomatic. A NAAT may be appropriate instead. Recent infection can affect test choice because PCR can remain positive for up to 90 days. Ask the clinician for a plan if you are taking a post-exposure medicine or need a particular form. Do not wait until day 5 to request a time-limited preventive medication assessment.
CDC says symptoms may appear 2–14 days after exposure, with variation between people and variants. Not everyone develops symptoms. There is no single day when a test will become positive for every exposed person. Timing and the assay both matter, and an early negative result does not guarantee no infection. Record the exposure and symptom dates and follow an appropriate testing plan. Symptoms or a positive result require an active-infection assessment, rather than assuming a post-exposure preventive prescription will treat the illness.
Exposure alone does not establish that you became infected, and there is no reliable countdown that certifies when an individual is contagious. COVID-19 can spread before symptoms or without symptoms. An early negative test cannot clear you, and a later positive PCR can persist after recovery without directly measuring infectiousness. Use the current respiratory precautions and the clinician’s testing advice, especially around someone at higher risk. If symptoms develop, stay home and away from others while arranging care. A preventive medicine does not certify that you cannot transmit the virus.
If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact Sharad Suri at service@naomedical.com or by phone at (917) 633-1548 Extension 288. In our goal to answer your questions as quick as possible, we use the assistance of a large language model wherever applicable. If there are any errors or concerns, please bring it to our attention by emailing us.
Enter your phone number to begin scheduling your appointment.
You will be redirected to complete the appointment booking. Next: Book Appointment
Nao Medical will never sell your information to a third party.
Choose urgent care for a non-emergency illness or minor injury. For preventive visits and ongoing management, explore primary care at this location.
Visiting later? Review after-hours options and confirm clinic hours before traveling. For a life-threatening emergency, call 911.
(917) 310-3371
Facebook
Instagram
Twitter
LinkedIn
